Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity

Table 3

HLA class I and class II typing before and after HSCT (Case A).

HLA class I	A*-1	A*-2	B*-1	B*-2	C*-1	C*-2
Patient before Tx	03 : 01	24 : 02	07 : 02	13 : 02	06 : 02	07 : 02
Sister	03 : 01	24 : 02	07 : 02	08 : 01	07 : 01	07 : 02
Patient (pB) after Tx	03 : 01	24 : 02	07 : 02	08 : 01	07 : 01	07 : 02
LAIP pos. cells	03 : 01		07 : 02			07 : 02
HLA class II	DRB1*-1	DRB1*-2	DQB1*-1	DQB1*-2	DPB1*-1	DPB1*-2
Patient before Tx	01 : 01	07 : 01	02 : 02	05 : 01	n.d.	n.d.
Sister	01 : 01	03 : 01	02 : 01	05 : 01	n.d.	n.d.
Patient (pB) after Tx	01 : 01	03 : 01	02 : 01	05 : 01	04 : 01	04 : 01
LAIP pos. cells	01 : 01			05 : 01	04 : 01

Abbreviations: pB: peripheral blood; LAIP: leukemia-associated aberrant immunophenotypes; n.d.: no data.